Categories
Lung Cancer News
- Predictors of talc pleurodesis outcome in patients with malignant pleural effusions 1 year 43 weeks old, lnn cancer rss feed .rss extention
- Systematic review of symptom control and quality of life in studies on chemotherapy for advanced non-small cell lung cancer: How CONSORTed are the data? 1 year 43 weeks old, lnn cancer rss feed .rss extention
- Frequent p16 inactivation by homozygous deletion or methylation is associated with a poor prognosis in Japanese patients with pleural mesothelioma 1 year 43 weeks old, lnn cancer rss feed .rss extention
- Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results 1 year 43 weeks old, lnn cancer rss feed .rss extention
- Expression of excision repair cross-complementation group 1 and class III β-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer 1 year 43 weeks old, lnn cancer rss feed .rss extention
Cancer News
- Predictors of talc pleurodesis outcome in patients with malignant pleural effusions 1 year 43 weeks old, lnn cancer rss feed .rss extention
- Systematic review of symptom control and quality of life in studies on chemotherapy for advanced non-small cell lung cancer: How CONSORTed are the data? 1 year 43 weeks old, lnn cancer rss feed .rss extention
- Frequent p16 inactivation by homozygous deletion or methylation is associated with a poor prognosis in Japanese patients with pleural mesothelioma 1 year 43 weeks old, lnn cancer rss feed .rss extention
- Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results 1 year 43 weeks old, lnn cancer rss feed .rss extention
- Expression of excision repair cross-complementation group 1 and class III β-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer 1 year 43 weeks old, lnn cancer rss feed .rss extention
Lymphoma News
- NHL: Current Treatments and Emerging Therapies - Part 2 1 year 44 weeks old, Lymphoma testing XML News
- NHL: Current Treatments and Emerging Therapies - Part 1 1 year 44 weeks old, Lymphoma testing XML News
